A careful evaluation of the therapeutic choice is necessary in every phase of diabetes progression


View Publication Info
Field Value
Title A careful evaluation of the therapeutic choice is necessary in every phase of diabetes progression
Creator Malighetti, Maria Elena
Description National and international diabetes guidelines recommend achieving a target value of glycated hemoglobin value that is dependent upon various factors including patient age, disease duration, co-morbidities, life expectancy and socio-economic conditions. The drug of choice is usually metformin, which can be associated with different classes of oral and injective drugs including insulin, in order to optimize the glycemic balance with the lowest possible risk of hypoglycemic episodes. The clinical case we report shows how a correct therapeutic choice, specifically with linagliptin, can reach a good glycemic control even in elderly subjects, suffering from diabetes mellitus for many years, starting from a severe metabolic imbalance after a multi-year therapy with sulphonylureas (Diabetology).
Publisher Aboutscience Srl
Date 2018-09-20
Type info:eu-repo/semantics/article
Case report
Format application/pdf
Identifier https://journals.aboutscience.eu/index.php/aboutopen/article/view/141
Source AboutOpen; V. 4 N. 1 (2018): January - December 2018; 137-139
AboutOpen; Vol 4 No 1 (2018): January - December 2018; 137-139
Language eng
Relation https://journals.aboutscience.eu/index.php/aboutopen/article/view/141/97
Rights Copyright (c) 2018 The authors

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us


Copyright © 2015-2018 Simon Fraser University Library